# Ceftazidime

NDC: 25021-129
Generic name: ceftazidime
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20080515

FDA application: ANDA062640

## Active ingredients

- CEFTAZIDIME: 6 g/30mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-129"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-129
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aec64360-8452-4987-a366-a5a4f8762ab6